Q2 2022 EPS Estimates for Agilent Technologies, Inc. (NYSE:A) Decreased by Analyst

Agilent Technologies, Inc. (NYSE:A) – Jefferies Financial Group lowered their Q2 2022 EPS estimates for shares of Agilent Technologies in a research note issued on Tuesday, November 23rd. Jefferies Financial Group analyst B. Couillard now forecasts that the medical research company will post earnings of $1.07 per share for the quarter, down from their prior estimate of $1.12. Jefferies Financial Group has a “Buy” rating and a $185.00 price objective on the stock.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, November 22nd. The medical research company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.04. The business had revenue of $1.66 billion for the quarter, compared to analysts’ expectations of $1.66 billion. Agilent Technologies had a return on equity of 26.12% and a net margin of 16.12%. The firm’s quarterly revenue was up 11.9% compared to the same quarter last year. During the same quarter last year, the business earned $0.98 earnings per share.

A number of other brokerages have also recently issued reports on A. Wells Fargo & Company raised their target price on Agilent Technologies from $150.00 to $180.00 and gave the stock an “overweight” rating in a report on Wednesday, August 18th. Stifel Nicolaus raised their target price on Agilent Technologies from $162.00 to $169.00 and gave the stock a “hold” rating in a report on Tuesday. KeyCorp raised their target price on Agilent Technologies from $160.00 to $195.00 and gave the stock an “overweight” rating in a report on Wednesday, August 18th. SVB Leerink raised their target price on Agilent Technologies from $170.00 to $175.00 and gave the stock an “outperform” rating in a report on Tuesday. Finally, Robert W. Baird lifted their price objective on Agilent Technologies from $144.00 to $170.00 and gave the company an “outperform” rating in a report on Wednesday, August 18th. One investment analyst has rated the stock with a hold rating and eighteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $151.75.

Shares of A opened at $152.97 on Thursday. The company has a current ratio of 2.11, a quick ratio of 1.63 and a debt-to-equity ratio of 0.55. Agilent Technologies has a 1 year low of $112.47 and a 1 year high of $179.57. The stock has a market cap of $46.31 billion, a P/E ratio of 47.80, a price-to-earnings-growth ratio of 2.67 and a beta of 0.98. The stock’s 50-day moving average price is $159.22 and its two-hundred day moving average price is $154.31.

Large investors have recently bought and sold shares of the business. Cambridge Trust Co. boosted its stake in shares of Agilent Technologies by 4.1% during the 3rd quarter. Cambridge Trust Co. now owns 45,188 shares of the medical research company’s stock worth $7,119,000 after acquiring an additional 1,762 shares during the period. EP Wealth Advisors LLC boosted its stake in shares of Agilent Technologies by 78.9% during the 3rd quarter. EP Wealth Advisors LLC now owns 7,820 shares of the medical research company’s stock worth $1,232,000 after acquiring an additional 3,448 shares during the period. Wealthsource Partners LLC bought a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $242,000. National Pension Service boosted its stake in shares of Agilent Technologies by 1.9% during the 3rd quarter. National Pension Service now owns 507,826 shares of the medical research company’s stock worth $79,998,000 after acquiring an additional 9,630 shares during the period. Finally, Kentucky Retirement Systems Insurance Trust Fund bought a new stake in Agilent Technologies in the 3rd quarter valued at $1,275,000.

In other Agilent Technologies news, SVP Padraig Mcdonnell sold 1,500 shares of the business’s stock in a transaction that occurred on Friday, November 19th. The stock was sold at an average price of $165.00, for a total transaction of $247,500.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 26th. Investors of record on Tuesday, January 4th will be given a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a yield of 0.55%. The ex-dividend date is Monday, January 3rd. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.19. Agilent Technologies’s dividend payout ratio (DPR) is currently 24.38%.

Agilent Technologies Company Profile

Agilent Technologies, Inc engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets; Diagnostics and Genomics; and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level.

Read More: Why Invest in Dividend Achievers?

Earnings History and Estimates for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.